Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus.
about
Profile of etravirine for the treatment of HIV infectionClinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen.Authentic HIV-1 integrase inhibitors.The role of etravirine in the management of treatment-experienced pediatric patients with HIV.Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokineticsProfile of darunavir in the treatment of HIV-infected pediatric and adolescent patients.Pharmacokinetic evaluation of etravirine.Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection.Early outcomes of darunavir- and/or raltegravir-based antiretroviral therapy in children with multidrug-resistant HIV at a pediatric center in Botswana.Raltegravir: a review of its use in the management of HIV-1 infection in children and adolescents.Use of Integrase Inhibitors in HIV-Infected Children and Adolescents.Darunavir: A Review in Pediatric HIV-1 Infection.Inhibiting the HIV integration process: past, present, and the future.Genotype-guided antiretroviral regimens in children with multidrug-resistant HIV-1 infection.Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients
P2860
Q33635039-773452A2-D1DE-4DB2-ADDF-D5AF0A15438CQ34144189-4BBBC503-3B50-49B2-807B-64323E73FF20Q36145625-B214DA99-0265-4CF3-ABD2-383F7ED37213Q36772619-70186E9C-3F17-45CD-91B9-BC6D000B4563Q37551700-2FCF81AF-54C1-4CE1-88BE-CEF0A94EAF0BQ37589028-CB76B8D4-F093-41AE-A30A-039CB078F609Q37809537-C74360EF-0340-4862-B1AE-3643F95AC116Q37816391-5E42AF80-2571-4D48-85A8-D7F25E1AC3E8Q38073734-4C978204-748E-44FE-AA42-618128EADC09Q38166286-9126EEE9-9324-4D95-BE7F-BC5C527E078FQ38560855-E62C671E-39D5-4819-909C-6F08E85CBEE5Q38577433-698B3AC5-B40A-4068-BA17-AC5DC9017A0FQ39352071-BA626196-9658-4DA2-B794-21316E72FE62Q39901450-12EBFA82-A88E-498B-996C-FC86C802C8B1Q56835972-34BD2E2A-6DA8-48E1-A921-6ADA5D714E0E
P2860
Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Raltegravir, etravirine and r- ...... ith multidrug-resistant virus.
@en
Raltegravir, etravirine and r- ...... ith multidrug-resistant virus.
@nl
type
label
Raltegravir, etravirine and r- ...... ith multidrug-resistant virus.
@en
Raltegravir, etravirine and r- ...... ith multidrug-resistant virus.
@nl
prefLabel
Raltegravir, etravirine and r- ...... ith multidrug-resistant virus.
@en
Raltegravir, etravirine and r- ...... ith multidrug-resistant virus.
@nl
P2093
P1433
P1476
Raltegravir, etravirine and r- ...... ith multidrug-resistant virus.
@en
P2093
Catherine Tamalet
Christian Rabaud
Ghislaine Firtion
Hugues Aumaître
Isabelle Thuret
Joëlle Tricoire
Marie-Laure Chaix
Pierre Frange
Stéphane Blanche
Véronique Reliquet
P304
P356
10.1097/QAD.0B013E328331A456
P407
P577
2009-11-01T00:00:00Z